Robert E. Lee Trout
VenatoRx Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Marine Sponges and Natural Products, Antibiotics Pharmacokinetics and Efficacy, Pharmaceutical and Antibiotic Environmental Impacts, Ion Channels and Receptors
Most-Cited Works
- → Systemic Activation of the Transient Receptor Potential Vanilloid Subtype 4 Channel Causes Endothelial Failure and Circulatory Collapse: Part 2(2008)291 cited
- → Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections(2019)285 cited
- → VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Enterobacterales and Pseudomonas aeruginosa(2019)208 cited
- → Spongistatin synthetic studies. 2. Assembly of the C(18–28) spiroketal(1997)52 cited
- → Cyclic Ketone Inhibitors of the Cysteine Protease Cathepsin K(2001)52 cited
- → Antagonists of the Calcium Receptor I. Amino Alcohol-Based Parathyroid Hormone Secretagogues(2009)42 cited
- → Discovery of VNRX-7145 (VNRX-5236 Etzadroxil): An Orally Bioavailable β-Lactamase Inhibitor for Enterobacterales Expressing Ambler Class A, C, and D Enzymes(2021)41 cited
- → Spongipyran synthetic studies. Total synthesis of (+)-spongistatin 2(2009)35 cited
- → Microbiological Characterization of VNRX-5236, a Broad-Spectrum β-Lactamase Inhibitor for Rescue of the Orally Bioavailable Cephalosporin Ceftibuten as a Carbapenem-Sparing Agent against Strains of Enterobacterales Expressing Extended-Spectrum β-Lactamases and Serine Carbapenemases(2021)31 cited
- → Azepanone-Based Inhibitors of Human Cathepsin L(2005)25 cited